News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
New COVID-19 vaccine for older adults gets FDA nod as fresh variant emerges
The World Health Organization has tracked a new COVID-19 variant that has emerged across multiple region. Amid this, the Food and Drug Administration has approved a COVID-19 vaccine from Moderna that offers added protection for older adults and people with health risks.
Federal health officials have changed the game for COVID vaccine access. Pregnant moms and others who rely on them to protect a high-risk family member are scared.
Dr. Marty Makary, the Johns Hopkins surgeon and professor whom President Donald Trump tapped to lead the U.S. Food and Drug ...
1don MSN
Rep. Marjorie Taylor Greene slams FDA green lighting of Moderna's mNEXSPIKE COVID-19 vaccine, describing the move as "Not ...
COVID-19 vaccine recommendations could be changing, according to the U.S. Food and Drug Administration. FDA leaders said on May 20 that clinical trials will be required to approve annual ...
Health Secretary Robert F. Kennedy Jr.’s decision to revoke the Covid vaccine recommendation for pregnant women has raised ...
While RFK Jr. said the coronavirus vaccine would be removed from the CDC schedule for healthy children, it’s still ...
The US Department of Health and Human Services, under Secretary Robert F. Kennedy Jr., has recently made significant changes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback